NKO Partners has advised Merkury Market on its acquisition of Erigone Beograd from Erigone Holding. Schoenherr reportedly advised Erigone Holding.
NKO Partners Advises MOL on Expansion of Sremski Karlovci Fuel Terminal
NKO Partners has advised MOL on the expansion of one of its Serbian fuel terminals in Sremski Karlovci, near Novi Sad via the acquisition of land from Dunav Oil and a construction and development arrangement with Naftachem for the extension works.
Grounded Investments: Why Real Estate Remains Serbia’s Favorite Asset
In Serbia’s real estate market, cultural tradition, financial caution, and limited alternatives intersect to create a unique investment landscape. NKO Partners Partner Branko Jankovic, BDK Advokati Partner Jelena Hrle, Bojovic Attorneys at Law Partner Marija Bojovic, Radovanovic Stojanovic & Partners Partner Milorad Gajic, and Gecic Law Partner Miodrag Jevtic discuss the enduring preference for property as a default investment, the historical experiences that continue to shape investor behavior, and the broader economic and geopolitical factors contributing to rising property prices across the country.
NKO Partners and BDK Advokati Advise on Emma Capital's Acquisition of Urion
NKO Partners has advised Emma Capital on the acquisition of a 65% stake in the Montenegrin MedTech company Urion. BDK Advokati advised the sellers.
NKO Advises and Radovanovic Stojanovic & Partners Advise on Sopharma's Full Acquisition of Pharmanova
NKO Partners has advised Sopharma on its full acquisition of Pharmanova. Radovanovic Stojanovic & Partners advised Pharmanova.
Serbia: The Intersection of Life Sciences and the Legal World
In Serbia, the regulatory authority for the life sciences sector is the Medicines and Medical Devices Agency. This agency oversees a diverse array of functions aimed at ensuring that medicines and medical devices are safe, of high quality, and effective. It is also responsible for approving clinical trials, ensuring adherence to the rigorous standards of good clinical practice. An essential component of this process is the ethics committee, an independent expert body that reviews clinical trials. This committee is composed of specialists from the fields of medicine, law, ethics, and other relevant disciplines, tasked with protecting the rights, safety, and well-being of trial subjects while also ensuring public protection of their rights.
NKO Partners Advises Dr Max on Acquisition of Zalfija Pharmacy Chain in Serbia
NKO Partners has advised Dr Max on its acquisition of Zalfija.
MMD Advokati and NKO Partners Advise on Sanders SH's Sale of Industrial Complex to Sano's Subsidiary
MMD Advokati has advised Sanders SH on the sale of its industrial complex to Sano's subsidiary in Serbia. NKO Partners advised the buyer, Sano Group.
NKO Partners and Joksovic, Stojanovic & Partners Advise on Levante HC's Acquisition of Megapharm
NKO Partners has advised Levante HC on the acquisition of Megapharm Beograd. Joksovic, Stojanovic & Partners advised Megapharm.
Gessel, Lovric Novokmet & Partners, and NKO Partners Join Horizons Alliance
Horizons Alliance has announced an expansion of its international legal network with the addition of Gessel in Poland, Lovric Novokmet & Partners in Croatia, and NKO Partners in Serbia.
NKO Partners Advises CTP on Acquisition of Land Site in Nis
NKO Partners has advised CTP on the acquisition of a land site in Nis, Serbia, from Eurosalon subsidiary Malford Beograd. The seller was advised by sole practitioner Goran Radovac.
NKO Partners and MMD Advokati Advise on Pro Group's Acquisition of Smart Tiger
NKO Partners has advised Pro Group on its acquisition of a 70% majority stake in Smart Tiger. MMD Advokati advised the seller, Slobodan Milivojevic.
Protests Leaving a Mark in Serbia: a Buzz Interview with Branko Jankovic of NKO Partners
Serbia’s legal market is influenced by ongoing political instability stemming from months-long student protests and the recent resignation of the Prime Minister, according to NKO Partners Junior Partner Branko Jankovic. This situation is expected to slow M&A activity, particularly in real estate and mining, though everyday employment-related legal work is on the rise.
NKO Partners and Joksovic, Stojanovic & Partners Advise on Mark Medical's Acquisition of Hermes-Pharma
NKO Partners has advised Mark Medical on the acquisition of Hermes-Pharma. Joksovic, Stojanovic & Partners advised the sellers.
NKO Partners Advises GreenChem on Acquisition of Adeco Blue
NKO Partners has advised GreenChem on the acquisition of Adeco Blue from Adeco. Sole practitioner Natalija Basic advised the sellers.
Stefan Savic Joins NKO Partners as Head of Antitrust and Competition Practice
Stefan Savic has joined NKO Partners as the firm's new Head of Antitrust and Competition Practice.
NKO Partners and Karanovic & Partners Advise on CTP's Land Acquisition in Kragujevac from Fiat Srbija
NKO Partners has advised CTP on the acquisition of land in Kragujevac, Serbia, from Stellantis’ subsidiary Fiat Srbija. Karanovic & Partners advised Fiat Srbija.
La Grande Nouvelle Du Jour: Serbia and France Sign Transformative Agreements
Serbia and France recently deepened their bilateral relations by signing multiple strategic agreements during French President Emmanuel Macron’s visit to Belgrade. These agreements span multiple sectors and are poised to have profound impacts on Serbia’s economy, business environment, and legislative landscape. Doklestic Repic & Gajin Partner Slobodan Doklestic and NKO Partners Partner Petar Orlic look at these agreements and their anticipated effects.
